Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -27.16% is 44% above its 2-year average of -48.08%, near the high end of its 2-year range (-93.84%–-27.16%).
As of the fiscal period ended Tuesday, June 30, 2026. 55.89% above its 12-month average of -61.57%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -27.16%.
RETURN ON INVESTED CAPITAL (ROIC)
-27.16%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-61.57%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+55.89%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-31.40%
median of 552 covered companies
CURRENT VS SECTOR MEDIAN
+13.50%
vs the sector median at left
Artiva Biotherapeutics, Inc.
Market Cap
$340.28M
Return on Invested Capital (ROIC)
-27.16%
TTM Avg
-61.57%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$342.72M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-35.18%
3Y Avg
-129.73%
5Y Avg
-103.61%
Market Cap
$337.38M
Return on Invested Capital (ROIC)
-40.51%
TTM Avg
-48.13%
3Y Avg
-48.38%
5Y Avg
-39.85%
Market Cap
$352.72M
Return on Invested Capital (ROIC)
-24.20%
TTM Avg
-33.45%
3Y Avg
-34.14%
5Y Avg
-28.75%
Market Cap
$353.30M
Return on Invested Capital (ROIC)
17.99%
TTM Avg
23.20%
3Y Avg
26.35%
5Y Avg
40.47%
Market Cap
$326.11M
Return on Invested Capital (ROIC)
-85.56%
TTM Avg
-114.55%
3Y Avg
-77.72%
5Y Avg
-63.50%
Market Cap
$354.62M
Return on Invested Capital (ROIC)
-59.29%
TTM Avg
-166.84%
3Y Avg
-79.03%
5Y Avg
-92.27%
Market Cap
$325.07M
Return on Invested Capital (ROIC)
-35.92%
TTM Avg
-35.67%
3Y Avg
-36.59%
5Y Avg
-30.23%
Market Cap
$357.79M
Return on Invested Capital (ROIC)
-1.84%
TTM Avg
-2.07%
3Y Avg
-43.39%
5Y Avg
-53.01%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | $340.28M | -27.16% | -61.57% | N/A | N/A |
| Agenus Inc. (AGEN)vs › | $342.72M | N/A | -35.18% | -129.73% | -103.61% |
| ClearPoint Neuro, Inc. (CLPT)vs › | $337.38M | -40.51% | -48.13% | -48.38% | -39.85% |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $352.72M | -24.20% | -33.45% | -34.14% | -28.75% |
| Embecta Corp. (EMBC)vs › | $353.30M | 17.99% | 23.20% | 26.35% | 40.47% |
| Cabaletta Bio, Inc. (CABA)vs › | $326.11M | -85.56% | -114.55% | -77.72% | -63.50% |
| Opus Genetics, Inc. (IRD)vs › | $354.62M | -59.29% | -166.84% | -79.03% | -92.27% |
| C4 Therapeutics, Inc. (CCCC)vs › | $325.07M | -35.92% | -35.67% | -36.59% | -30.23% |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $357.79M | -1.84% | -2.07% | -43.39% | -53.01% |
| CapsoVision, Inc. (CV)vs › | $322.44M | -164.32% | -159.25% | -125.06% | -125.06% |
ROIC
-27.2%
ROE
-26.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -27.16% |
| 2026-03-31 | -93.84% |
| 2025-12-31 | -74.28% |
| 2025-09-30 | -61.13% |
| 2025-06-30 | -51.43% |
| 2025-03-31 | -41.86% |
| 2024-12-31 | -34.10% |
| 2024-09-30 | -28.73% |
| 2024-06-30 | -48.92% |
| 2024-03-31 | -34.43% |
| 2023-12-31 | -33.02% |
